Cell line · CVCL_1483

NCI-H1650

Cancer cell line, Homo sapiens. Minimally invasive lung adenocarcinoma. 67 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. NCI-H1650. Cell lines, record CVCL_1483. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1483

On this page

Cell line

As Cellosaurus gives it.

Name: NCI-H1650
Accession: CVCL_1483
RRID: RRID:CVCL_1483
Synonyms: H1650, H-1650, H1650_CO, NCIH1650
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 27Y
Category: Cancer cell line
Diseases: Minimally invasive lung adenocarcinoma (NCIt C2923)
Derived from: Pleural effusion (metastatic)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers67

Paper	Journal	Year	How we know	Source
Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer.	Int J Mol Sci	2026	Its Methods give the RRID and name the line	PubMed
E3 ubiquitin ligase MAGI3‑mediated TAZ ubiquitination suppresses the non‑small cell lung cancer occurrence and development by targeting the Wnt pathway.	Int J Oncol	2026	Its Methods give the RRID and name the line	PubMed
HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma.	J Exp Clin Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in NSCLC.	Cell Oncol (Dordr)	2026	Its Methods give the RRID and name the line	PubMed
MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non-Small Cell Lung Cancer.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
A Zinc Finger Protein-Based Prognostic Model in Lung Adenocarcinoma Identifies FGD3 as a Marker Associated with Lorlatinib Resistance.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Bioprinted Tumor Microenvironment Models Reveal Immune Evasion and Guide CAR-NK Therapeutic Strategies.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
CD146+ pericyte-like lung cancer brain metastatic stem cells promote tumor angiogenesis through dual regulatory effects on the VEGF/VEGFR axis.	Theranostics	2026	Its Methods give the RRID and name the line	PubMed
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 67

See all 67 papers

Relatives6

Relation	Cell line	Accession	Source
Derived from it	H1650-ER1	CVCL_4V01	Cell lines
Derived from it	H1650/LKB1shRNA	CVCL_E7UX	Cell lines
Derived from it	H1650/pLKO.1	CVCL_E7UY	Cell lines
Derived from it	HyCyte NCI-H1650 stable cell line for hDTYMK overexpression	CVCL_F4U7	Cell lines
Derived from it	NCI-H1650-GAS-Luc2	CVCL_C9CY	Cell lines
Derived from it	NCI-H1650-Luc	CVCL_4W95	Cell lines

Cell banks7

Cell bank	Catalog number	Source
ATCC	CRL-5883	ATCC
AddexBio	C0016015/4961	Cellosaurus
CLS	305059	CLS
Hysigen	TCH-C272	Hysigen
ICLC	HTL06002	ICLC
KCLB	91650	KCLB
Ubigene	YC-C110	Ubigene

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1483

GET https://conductscience.org/api/cell-lines/v1/CVCL_1483/papers?page=2

API reference For AI assistants